187 related articles for article (PubMed ID: 33866550)
21. Beneficial or detrimental activity of regulatory T cells, indoleamine 2,3-dioxygenase, and heme oxygenase-1 in the lungs is influenced by the level of virulence of
Lozano-Ordaz V; Rodriguez-Miguez Y; Ortiz-Cabrera AE; Hernandez-Bazan S; Mata-Espinosa D; Barrios-Payan J; Saavedra R; Hernandez-Pando R
Front Cell Infect Microbiol; 2023; 13():1105872. PubMed ID: 37284503
[TBL] [Abstract][Full Text] [Related]
22. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
API Consensus Expert Committee
J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic effects of traditional Chinese medicine Niubeixiaohe in mouse tuberculosis models.
Liang Y; Wang X; Song J; Wang L; Chen D; Yang Y; Bai X; Wang J; Shi Y; Chen S; Liu J; Yang C; Luo H; Liu G; Wu X
J Ethnopharmacol; 2017 Jan; 195():318-323. PubMed ID: 27884716
[TBL] [Abstract][Full Text] [Related]
24. Ursolic and oleanolic acids as antimicrobial and immunomodulatory compounds for tuberculosis treatment.
Jiménez-Arellanes A; Luna-Herrera J; Cornejo-Garrido J; López-García S; Castro-Mussot ME; Meckes-Fischer M; Mata-Espinosa D; Marquina B; Torres J; Hernández-Pando R
BMC Complement Altern Med; 2013 Oct; 13():258. PubMed ID: 24098949
[TBL] [Abstract][Full Text] [Related]
25. Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
Tomioka H
Curr Pharm Des; 2014; 20(27):4305-6. PubMed ID: 24245755
[TBL] [Abstract][Full Text] [Related]
26. Course of murine tuberculosis and response to first-line therapy depends on route of infection and inoculum size.
de Steenwinkel JE; ten Kate MT; de Knegt GJ; Verbrugh HA; van Belkum A; Hernandez-Pando R; Bakker-Woudenberg IA
Int J Tuberc Lung Dis; 2011 Nov; 15(11):1478-84, i. PubMed ID: 22008760
[TBL] [Abstract][Full Text] [Related]
27. Pre-Diabetes Increases Tuberculosis Disease Severity, While High Body Fat Without Impaired Glucose Tolerance Is Protective.
Sinha R; Ngo MD; Bartlett S; Bielefeldt-Ohmann H; Keshvari S; Hasnain SZ; Donovan ML; Kling JC; Blumenthal A; Chen C; Short KR; Ronacher K
Front Cell Infect Microbiol; 2021; 11():691823. PubMed ID: 34295838
[TBL] [Abstract][Full Text] [Related]
28. Clofazimine protects against Mycobacterium tuberculosis dissemination in the central nervous system following aerosol challenge in a murine model.
Baijnath S; Moodley C; Ngcobo B; Singh SD; Kruger HG; Arvidsson PI; Naicker T; Pym A; Govender T
Int J Antimicrob Agents; 2018 Jan; 51(1):77-81. PubMed ID: 28843822
[TBL] [Abstract][Full Text] [Related]
29. Immunoendocrine alterations during human tuberculosis as an integrated view of disease pathology.
Bottasso O; Bay ML; Besedovsky H; del Rey A
Neuroimmunomodulation; 2009; 16(2):68-77. PubMed ID: 19212126
[TBL] [Abstract][Full Text] [Related]
30. Exendin-4 exerts osteogenic actions in insulin-resistant and type 2 diabetic states.
Nuche-Berenguer B; Moreno P; Portal-Nuñez S; Dapía S; Esbrit P; Villanueva-Peñacarrillo ML
Regul Pept; 2010 Jan; 159(1-3):61-6. PubMed ID: 19586609
[TBL] [Abstract][Full Text] [Related]
31. Rapid, simple in vivo screen for new drugs active against Mycobacterium tuberculosis.
Nikonenko BV; Samala R; Einck L; Nacy CA
Antimicrob Agents Chemother; 2004 Dec; 48(12):4550-5. PubMed ID: 15561824
[TBL] [Abstract][Full Text] [Related]
32. Metformin: Candidate host-directed therapy for tuberculosis in diabetes and non-diabetes patients.
Restrepo BI
Tuberculosis (Edinb); 2016 Dec; 101S():S69-S72. PubMed ID: 27720378
[TBL] [Abstract][Full Text] [Related]
33. HIS-388, a novel orally active and long-acting 11β-hydroxysteroid dehydrogenase type 1 inhibitor, ameliorates insulin sensitivity and glucose intolerance in diet-induced obesity and nongenetic type 2 diabetic murine models.
Okazaki S; Takahashi T; Iwamura T; Nakaki J; Sekiya Y; Yagi M; Kumagai H; Sato M; Sakami S; Nitta A; Kawai K; Kainoh M
J Pharmacol Exp Ther; 2014 Oct; 351(1):181-9. PubMed ID: 25100752
[TBL] [Abstract][Full Text] [Related]
34. Risk Factors for Multidrug-resistant Tuberculosis.
Rumende CM
Acta Med Indones; 2018 Jan; 50(1):1-2. PubMed ID: 29686169
[TBL] [Abstract][Full Text] [Related]
35. Dynamics of adrenal steroids are related to variations in Th1 and Treg populations during Mycobacterium tuberculosis infection in HIV positive persons.
Quiroga MF; Angerami MT; Santucci N; Ameri D; Francos JL; Wallach J; Sued O; Cahn P; Salomón H; Bottasso O
PLoS One; 2012; 7(3):e33061. PubMed ID: 22431997
[TBL] [Abstract][Full Text] [Related]
36. Chemoprotective effects of butanol fraction
Okolie AC; Kale OE; Osilesi O
Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 28790167
[TBL] [Abstract][Full Text] [Related]
37. Changes in Host Response to
Segura-Cerda CA; López-Romero W; Flores-Valdez MA
Front Cell Infect Microbiol; 2019; 9():342. PubMed ID: 31637222
[TBL] [Abstract][Full Text] [Related]
38. Identification of pyrvinium pamoate as an anti-tuberculosis agent
Guan Q; Zhan L; Liu ZH; Pan Q; Chen XL; Xiao Z; Qin C; Zhang XL
Emerg Microbes Infect; 2020; 9(1):302-312. PubMed ID: 32013776
[TBL] [Abstract][Full Text] [Related]
39. [Prospects for development of new antituberculous drugs].
Tomioka H
Kekkaku; 2002 Aug; 77(8):573-84. PubMed ID: 12235850
[TBL] [Abstract][Full Text] [Related]
40. A novel benzothiazinethione analogue SKLB-TB1001 displays potent antimycobacterial activities in a series of murine models.
Gao C; Ye TH; Peng CT; Shi YJ; You XY; Xiong L; Ran K; Zhang LD; Zeng XX; Wang NY; Yu LT; Wei YQ
Biomed Pharmacother; 2017 Apr; 88():603-609. PubMed ID: 28142116
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
